Trump’s Executive Order Halts Dangerous Gain-of-Function Research
Originally published: 2025-05-06
Introduction
On May 5, 2025, President Donald Trump signed a landmark executive order banning all federal funding for "dangerous" gain-of-function (GOF) research, with a sharp focus on halting support for risky studies in countries like China and Iran. This bold move prioritizes public safety by eliminating U.S. backing for research that could trigger pandemics. The order is a critical step toward safeguarding Americans and reinforcing national security, earning praise for its proactive approach.
> "This executive order stops taxpayer dollars from funding experiments that could endanger our nation."
> — White House Statement, May 5, 2025
Understanding Gain-of-Function Research
Gain-of-function research involves altering pathogens, such as viruses, to make them more transmissible or lethal, often under the guise of studying pandemic potential. However, the risks of lab leaks or misuse are significant, as seen in controversies surrounding bat coronavirus studies at institutions like the Wuhan Institute of Virology. President Trump’s order targets these high-risk experiments, particularly those conducted abroad, to prevent catastrophic biological incidents.
The Executive Order: A Strong Stance
Signed on Trump’s first day back in office, the executive order prohibits federal funding for GOF research that manipulates viruses or biological agents in ways that could increase their pandemic potential. It explicitly blocks support for such research in countries deemed adversarial, like China and Iran, and strengthens oversight of domestic biological research to ensure compliance with rigorous safety standards. The White House has emphasized that this policy protects Americans while maintaining U.S. leadership in biotechnology and biosecurity.
> "We will not let foreign labs conducting dangerous experiments threaten our security."
> — President Donald Trump, May 5, 2025
Historical Context: Addressing a Persistent Threat
Concerns about GOF research are not new. The Obama administration paused federal funding for certain GOF studies in 2014 due to safety risks, but the pause was lifted in 2017 during Trump’s first term with added oversight. The COVID-19 pandemic heightened scrutiny, with many pointing to GOF research as a potential risk factor in global health crises. Earlier in 2025, reports indicated the Trump administration was considering a temporary pause on GOF funding, but the May 5 order takes a more decisive approach, comprehensively banning federal support for high-risk research.
A Victory for Public Safety
Supporters, including Republican lawmakers like Congressman Morgan Griffith, hail the executive order as a long-overdue measure to mitigate the dangers of GOF research. By cutting off funding for risky experiments, particularly those abroad, the policy reduces the likelihood of lab leaks and enhances national security. The ban also addresses concerns about past projects, such as the EcoHealth Alliance’s collaboration with the Wuhan Institute of Virology, which raised red flags about accountability and oversight.
> "This is a common-sense move to keep Americans safe from reckless science."
> — Congressman Morgan Griffith, May 6, 2025
Looking Ahead: A Safer Future
The executive order sets a clear precedent for prioritizing biosecurity in U.S. policy. By eliminating federal support for dangerous GOF research, the Trump administration is taking proactive steps to prevent future biological threats. The policy’s focus on foreign research ensures that sensitive experiments are not conducted in environments with questionable oversight, while domestic standards are tightened to maintain safety.
As the order takes effect, it will likely reshape the landscape of biological research, steering resources toward safer, more secure projects. This move reinforces America’s commitment to protecting its citizens from preventable risks while maintaining its global leadership in biotechnology.
Conclusion
President Trump’s executive order banning federal funding for gain-of-function research is a decisive victory for public safety and national security. By targeting high-risk experiments, especially those in foreign labs, the policy addresses critical vulnerabilities in global biosecurity. As America moves forward, this order stands as a testament to the administration’s commitment to protecting its citizens from the dangers of reckless science.
> "Our priority is clear: no more funding for experiments that could spark the next pandemic."
> — White House Official, May 2025
